Any change that affects the molecular triad – OPG/RANKL/RANK – results in an alteration of bone remodeling that, if not duly controlled, may lead to the development of skeletal abnormalities characterized by decreased (osteoporosis) or increased (osteopetrosis) bone mass5–10. Here, TNFRSF11B is linked to osteoporosis.